Hematologic Neoplasms: all 1,494 studies
Page 4 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentEnrolling by invitationNCT05600933
- Global Cardio Oncology RegistryRecruitingNCT05598879
- Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDSAvailableNCT05593185
- A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) BiopsyRecruitingNCT05583734Not applicable
- Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged NeutropeniaRecruitingNCT05537896Phase 2
- Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological MalignanciesRecruitingNCT05536154Not applicable
- Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) PatientsRecruitingNCT05529069Phase 2
- Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological MalignanciesRecruitingNCT05528887Phase 1
- Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological MalignanciesRecruitingNCT05510089Not applicable
- The Endothelial Cell Dysfunction and Outcome Project for Hematological NeoplasmsRecruitingNCT05502887
- Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological MalignanciesRecruitingNCT05488548Phase 1
- An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic TumorsRecruitingNCT05481502Not applicable
- Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesRecruitingNCT05476770Phase 1
- APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICURecruitingNCT05475600Not applicable
- Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...RecruitingNCT05470491Phase 1/2
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruitingNCT05463796
- The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell TransplantationRecruitingNCT05436418Phase 1/2
- Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical TransplantationRecruitingNCT05417971
- Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ MalignanciesRecruitingNCT05391490Phase 1
- Response to Influenza Vaccination in Pediatric Oncology PatientsRecruitingNCT05384288
- Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological MalignancyRecruitingNCT05379738Not applicable
- SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)RecruitingNCT05375643Not applicable
- The Association of Microbiota Composition With cGVHD After Allo-HSCTRecruitingNCT05355675
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
- Long-Term Follow-up StudyEnrolling by invitationNCT05332054
- Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesRecruitingNCT05327023Phase 1/2
- Improving Comprehensive Care of Cancer PatientsRecruitingNCT05323409Not applicable
- Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)RecruitingNCT05322850Phase 1/2
- Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric OncologyRecruitingNCT05306509Not applicable
- International Leukemia Target BoardRecruitingNCT05270096
- CXCR4-targeted PET/CT Imaging in Hematological MalignanciesRecruitingNCT05255926Not applicable
- Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell TransplantationRecruitingNCT05250362Phase 1/2
- Early Integration of Palliative and Supportive Care in Cellular TherapyRecruitingNCT05190653Not applicable
- Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)RecruitingNCT05178472Not applicable
- oGVHD After Bone Marrow Transplantation: a Territory-wide CohortRecruitingNCT05170347
- The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer DrugsRecruitingNCT05159245Phase 2
- Avera Cancer Sequencing and Analytics Protocol (ASAP)RecruitingNCT05142033
- Role of Gut Microbiome in Cancer TherapyRecruitingNCT05112614
- Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological MalignancesRecruitingNCT05110742Phase 1/2
- Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related TherapiesRecruitingNCT05108519
- Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RICRecruitingNCT05066412Phase 1
- A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic MalignanciesNot yet recruitingNCT05055791Phase 1/2
- Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi MethodRecruitingNCT05054413
- Immunological Profile for Patients Treated With CAR-T CellsNot yet recruitingNCT05054231Not applicable
- Solving Riddles Through SequencingRecruitingNCT05046444
- Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite StudiesEnrolling by invitationNCT05041309
- Function of Platelets Used for TransfusionsEnrolling by invitationNCT05038722
- The Impact of COVID-19 on Pulmonary ProceduresRecruitingNCT05022446
- Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic MalignanciesRecruitingNCT05011045
- Optical Genome Mapping in Hematological MalignanciesRecruitingNCT05009537
- (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisRecruitingNCT04996875Phase 2
- Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and EthiopiaRecruitingNCT04984551Phase 2
- Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCTRecruitingNCT04959903Phase 1/2
- Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesRecruitingNCT04959175Phase 1/2
- Faecal Microbiota Transplantation After Allogeneic Stem Cell TransplantationRecruitingNCT04935684Phase 2
- Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant SurvivorsRecruitingNCT04892823
- Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic MalignanciesRecruitingNCT04888338
- Adoption of Audio Recording in the Outpatient Supportive Care CenterNot yet recruitingNCT04871477
- Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma PatientsRecruitingNCT04844866Phase 2
- Membrane Target Detection for Leukemia TreatmentRecruitingNCT04841447
- Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS PatientsRecruitingNCT04809181Phase 2
- The Leukemia and Lymphoma Society (LLS) National Research RegistryRecruitingNCT04806295
- Expressive Writing for the Management of Stress in Cancer SurvivorsRecruitingNCT04776941Not applicable
- COVID-19 Vaccine Efficacy in Patients With Malignant PathologiesRecruitingNCT04776005
- Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.RecruitingNCT04771572Phase 1
- Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCTRecruitingNCT04764513Phase 1/2
- Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host DiseaseRecruitingNCT04744116Early Phase 1
- Covid-19 in Hematological MalignanciesRecruitingNCT04733729
- Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)RecruitingNCT04728893Phase 2
- Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised PatientsRecruitingNCT04712539Phase 2
- Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)RecruitingNCT04707300Phase 1/2
- Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell TransplantationRecruitingNCT04691284Not applicable
- Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological MalignanciesNot yet recruitingNCT04662788Early Phase 1
- LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological MalignanciesNot yet recruitingNCT04657965Early Phase 1
- A Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT04634552Phase 2
- GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant CyclophosphamideRecruitingNCT04622956Phase 1/2
- Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological MalignancyRecruitingNCT04599556Phase 1
- Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AMLRecruitingNCT04588922Phase 1/2
- Ruxolitinib and Decitabine for High Risk Hematological MalignanciesRecruitingNCT04582604Phase 1/2
- The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and SurvivorsRecruitingNCT04551378
- Aberrant Expression of CD56 in Patients With Hematologic Malignancies.RecruitingNCT04546945
- Mobile Health Application (PACT) to Improve Engagement in Advance Care PlanningRecruitingNCT04515810Not applicable
- Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological MalignanciesRecruitingNCT04470947
- Better Leukemia Diagnostics Through AI (BELUGA)RecruitingNCT04466059
- Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)RecruitingNCT04448184Phase 3
- Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 StudyRecruitingNCT04372524
- Integrated Multiomics and Multilevel Characterization of Haematological Disorders and MalignanciesRecruitingNCT04298892
- A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid MalignanciesRecruitingNCT04283006Early Phase 1
- Register of Blood Stem Cell TransplantationRecruitingNCT04263857
- Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side EffectsRecruitingNCT04242095
- A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological MalignancyRecruitingNCT04227015Early Phase 1
- Response to Chimeric Antigen Receptor (CAR)-T Cells Therapy in Patients With Hematologic Malignancies Depending on Tumor CharacteristicsNot yet recruitingNCT04209829
- Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesRecruitingNCT04068597Phase 1/2
- A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological MalignanciesAvailableNCT04008524
- Longitudinal Studies of Patient With FPDMMRecruitingNCT03854318
- HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and BortezomibRecruitingNCT03850366Phase 2
- Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic DiseaseRecruitingNCT03844360Phase 4
- Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic MalignanciesRecruitingNCT03838926Phase 1
- Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological MalignanciesRecruitingNCT03818334Phase 2/3
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1